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BiogenesisTMEM70 protein represents a novel ancillary factor of mammalian ATP synthase. We have investigated
import and processing of this factor in human cells using GFP- and FLAG-tagged forms of TMEM70 and speciﬁc
antibodies. TMEM70 is synthesized as a 29 kDa precursor protein that is processed to a 21 kDa mature form.
Immunocytochemical detection of TMEM70 showed mitochondrial colocalization with MitoTracker Red and
ATP synthase. Western blot of subcellular fractions revealed the highest signal of TMEM70 in isolated
mitochondria and mitochondrial location was conﬁrmed by mass spectrometry analysis. Based on analysis of
submitochondrial fractions, TMEM70 appears to be located in the inner mitochondrial membrane, in
accordance with predicated transmembrane regions in the central part of the TMEM70 sequence. Two-
dimensional electrophoretic analysis did not show direct interaction of TMEM70 with assembled ATP
synthase but indicated the presence of dimeric form of TMEM70. No TMEM70 protein could be found in cells
and isolated mitochondria from patients with ATP synthase deﬁciency due to TMEM70 c.317-2ANG mutation
thus conﬁrming that TMEM70 biosynthesis is prevented in these patients.tic part of ATP synthase; Fo,
ate dehydrogenase
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Biogenesis of eukaryotic ATP synthase is a stepwise process, in
which 16 different subunits assemble the structure of the enzyme
consisting of the F1 catalytic part and the membranous Fo part
connected together by two stalks [1,2]. The biosynthesis of individual
subunits and formation of the ATP synthase holoenzyme depend on
several speciﬁc helper proteins that are partly common to, and partly
unique to, higher and lower eukaryotes. Several yeast-speciﬁc factors
(NCA1-3, NAM1, AEP1-3 ATP22 and ATP25) are involved in mRNA
stability, translation and processing of mtDNA encoded subunits ATP6
and ATP9 [1,3–5] or their assembly (ATP10, ATP22). Additional factor
ATP23 [5,6], themetalloprotease with chaperone activity is implicated
in processing of ATP6 and its association with ATP9 oligomer. There
exists mammalian ortholog of ATP23 which contains a HEXXH motif
of the protease active site, but its function is unknown. The only two
yeast factors that are found in mammals [1,7,8], having identical
function are the F1 chaperones, ATPAF1 and ATPAF2, interacting withF1 subunits β and α. Both are absolutely essential for assembly of the
functional α3β3 heterooligomer. The FMC1, the third factor involved
in F1 assembly in yeast at high temperature [9] is again speciﬁc for
yeast. Till now, only one essential ancillary factor, the TMEM70
protein, has been found in mammals being absent in yeast and fungi
[10,11]. The mutations in TMEM70 gene were found to be responsible
for isolated deﬁciency of ATP synthase leading to a severe mitochon-
drial disease [10,12]. The enzyme defect was rescued by the
wtTMEM70. The TMEM70 protein was identiﬁed as a putative
mitochondrial protein that fulﬁls the criteria of MITOCARTA [13,14].
The biological roles, as well as biogenesis of this protein remain
unknown. In this study we attempted to use tagged forms of TMEM70
and speciﬁc antibodies for characterization of expression, processing
and localization of this factor.
2. Materials and methods
2.1. Cell cultures
Human embryonic kidney cells (HEK293, CRL-1573, ATCC) were
grown in high-glucose DMEMmedium (PAA) supplemented with 10%
(v/v) fetal calf serum (PAA) at 37 °C in 5% CO2 in air. Fibroblasts were
grown in DMEM medium (Sigma) containing 10% fetal calf serum
(Sigma), penicillin (100 U/mL) and streptomycin (100 μg/mL), at
37 °C in 5% CO2 in air. Conﬂuent cells were harvested by trypsinization
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0.20 g/L KH2PO4).
2.2. Expression vectors
TMEM70 cDNA clone MHS1011-60493 was obtained from Open
Biosystems. Following the sequence veriﬁcation, the insert was
transferred into the mammalian expression vector pEF-DEST51
using the Gateway technology (Invitrogen). Resulting plasmids
TMEM70-pEF-DEST51 were propagated in Escherichia coli, isolated
and fully sequenced before the transfection. TMEM70-Flag cDNA
expression vector—the full-length human TMEM70 coding sequence
was ampliﬁed from the IMAGE clone 3631570 and inserted into the C-
FLAG fusion mammalian expression vector pCMV-Tag4 (Stratagene).
The ﬁdelity of the construct was conﬁrmed by sequencing. TMEM70-
GFP cDNA expression vector [13] was kindly provided by Dr V.K.
Mootha.
2.3. Transfections
Vectors were transfected into the ﬁbroblast or HEK293 cell lines
(2 μg of DNA/5×105 cells) using Nucleofector device and NHDF
nucleofection kit (Amaxa/Lonza), following the standard protocol. For
the transient expression of the TMEM70-FLAG fusion protein, cell
transfection was carried out with Express-In Transfection Reagent
(Open Biosystems). Transfected cell lines were cultured for 48 h on BD
Falcon 4-well CultureSlides.
2.4. Isolation of mitochondria
HEK293 cells (1×107) were harvested by trypsinization, washed
twice in PBS, re-suspended in isotonic STE buffer (250 mM sucrose,
10 mM Tris–HCl, pH 7.4, 1 mM EDTA, 0.2% (v/v) Protease Inhibitor
Cocktail (PIC, Sigma P8340)), and disrupted on ice using Dounce
homogenizer. Homogenate was centrifuged for 15 min at 600g and
4 °C, the post-nuclear supernatant was centrifuged for 25 min at
10,000g and 4 °C. The resulting supernatant corresponding to the
cytoplasm fraction was collected and the mitochondrial pellet was
washed by centrifugation with STE buffer.
Fibroblast mitochondria were isolated by the method utilizing the
hypotonic shock cell disruption [15]. To avoid proteolytic degradation,
the isolation medium (250 mM sucrose, 40 mM KCl, 20 mM Tris–HCl,
2 mM EGTA, pH 7.6) was supplemented with the 0.2% PIC. The
isolated mitochondria were stored at −80 °C.
Rat liver mitochondria for import studies were isolated by the
method of Enriquez et al. [16].
2.5. Submitochondrial fractionation
Fractionation of mitochondria from HEK293 cells was carried out
according to Satoh et al. [17] with slightmodiﬁcations. Brieﬂy, isolated
mitochondria were re-suspended in STE buffer at ﬁnal concentration
1 mg/mL and disrupted by repeated freezing-thawing 3 times
followed by sonication on ice for 5 s at 20% amplitude and 0.5 cycle
using an UP 200S Ultrasonic Processor (Hielscher, Germany).
Unbroken mitochondria were removed by centrifugation at 10,000g
for 10 min. The soluble mitochondrial proteins and membranes were
separated by centrifugation of the supernatant at 100,000g for 35 min.
The pellet was re-suspended in 100 mM sodium carbonate, pH 11.5,
and incubated at 4 °C and continuous vortexing for 30 min followed
by centrifugation at 100,000g and 4 °C for 40 min. Supernatant
containing membrane associated proteins was collected and the
pellet was re-suspended in STE buffer. All collected fractions were
kept at −80 °C until analysis.2.6. TMEM70 antibodies
The cDNA sequence encoding 50–260 AA of human TMEM70,
corresponding to expected mature part of the protein was cloned into
pMAL-c2 expression vector (New England Biolabs). The construct
with the correct sequence was introduced into the E. coli MAX
Efﬁciency DH5αF'IQ cells and the fusion protein MBP-TMEM70 was
expressed upon IPTG induction. Fusion protein was isolated from
sonicated and detergent solubilized cell lysate (20 mM Tris–HCl,
0.2 M NaCl, 1 mM EDTA, 1% Nonidet P-40) using amylose resin
column (New England Biolabs). The protein was eluted from the
column by 50 mMmaltose and directly used for rabbit immunization
(Open Biosystems).
2.7. Electrophoresis and Western blot analysis
SDS-PAGE, two-dimensional BN/SDS-PAGE and Western blot
analysis were performed by standard protocols as previously [18,19]
using speciﬁc primary antibodies against GFP (Santa Cruz Biotech-
nology), FLAG (Sigma), cytochrome c oxidase subunit Cox1, ATPase β
subunit, PDH E1 α subunit (Mitosciences), MtHSP70 (Alexis Bio-
chemicals), α-Tubulin (Cell Signaling), a mixture of antibodies to
respiratory chain proteins (MS603 to ATPase α, Core2, NDUFA9,
SDH70, Cox4; Mitosciences), or the polyclonal rabbit antibody to
TMEM70. The immunoblots were detected with peroxidase-conju-
gated secondary antibodies and SuperSignal West Femto Maximum
Sensitivity Substrate (Thermo Scientiﬁc) using VersaDoc 4000
Imaging System (Bio-Rad), or with ﬂuorescent secondary antibodies
(Alexa Fluor 680, Molecular Probes) on an Odyssey infrared imaging
system (LI-COR).
2.8. Immunocytochemistry
Fibroblast cells were grown on glass chamber slides (BD Falcon 4-
well CultureSlides). After 48 h, the cells were washed with PBS, ﬁxed
and permeabilized for 10 min with methanol at −20 °C or with
paraformaldehyde for 10 min at 4 °C. After blocking unspeciﬁc sites
with 5% FBS, cells were incubated overnight at 4 °C with indicated
antibody in 5% FBS followed by 60 min incubation at 37 °C with
ﬂuorophore-conjugated secondary antibody (1 μg/mL, Molecular
Probes). The following primary antibodies were used: mouse
monoclonal (MS503, Mitosciences) or polyclonal [20] to F1 β subunit,
mouse monoclonal to FLAG (Sigma), or rabbit polyclonal antibody to
TMEM70.
When using MitoTracker Red (Molecular Probes), cells were
incubated in 300 nM prewarmed medium solution of MitoTracker
Red at 37 °C for 15 min, washed with fresh prewarmedmedium, ﬁxed
and permeabilized. Nuclei were stained with 4',6-diamidino-2-
phenylindole (DAPI). Prepared slides were mounted in ﬂuorescence
mounting medium Immu-Mount (ShandonLipshaw) and analyzed by
confocal microscopy (Nikon Eclipse TE2000, Leica AOBS—Acusto-
Optical Beam Splitter) and/or epiﬂuorescent microscopy (wideﬁeld
epiﬂuorescent microscope Nikon Eclipse E400).
2.9. Mitochondrial import
Protein precursor was synthesized in the presence of 35S-
methionine using TNT T7 Quick Coupled Transcription/Translation
System (Promega) with plasmid vector or PCR product as a DNA
template, according to manufacturer's recommendation. Translation
product was centrifuged at 13,000g for 2 min and supernatant was
used for import to isolated rat liver mitochondria or human HEK293
mitochondria.
The import reaction was carried out in 50 μL of a medium
containing 25 mM sucrose, 75 mM sorbitol, 100 mM KCl, 10 mM
KH2PO4, 0.05 mM EDTA, 5 mMMgCl2, 10 mM Tris–HCl, 1 mg BSA/mL,
Fig. 1. The size of mature TMEM70. Western blot analysis of TMEM70-GFP (A) and TMEM70-FLAG (B) expressed in ﬁbroblast and HEK293 cells. (C) Alignment of human (NCBI GI:
34147498), rat (157823940), mouse (15030135) and bovine (148878159) TMEM70 protein sequence; arrow indicates predicted cleavage site of the TMEM70 precursor protein.
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isolated mitochondria. Incubation with 35S labeled-translation prod-
uct was performed for 30 min at 30 °C, in presence or absence of 4 μM
FCCP. Indicated samples were treated with 0.16 mg trypsin/mL for
20 min on ice. Then 4 μM PMSF (phenylmethanesulfonyl ﬂuoride)
was added to all samples and mitochondria were sedimented and
washed twice by centrifugation at 13,000g for 2 min at 4 °C. Samples
were analyzed by SDS-PAGE and radioactivity was detected using
BAS-5000 system (Fuji).2.10. Ethics
The project was approved by the Scientiﬁc Ethics Committees of
the 1st Faculty of Medicine of Charles University in Prague and
Institute of Physiology, Academy of Sciences of the Czech Republic.
Patient participation in the project was made on a voluntary basis
after oral and written information and consent according to the
Helsinki V Declaration.Fig. 2.Mature TMEM70 of ~21 kDa is absent in patients with ATP synthase deﬁciency. (A) W
and mitochondria. (B) Western blot detection of ATP synthase (β subunit), PDH (E1α subun
(P) with TMEM70 c.317-2ANG mutation.3. Results and discussion
As shown in Fig. 1A, the TMEM70-GFP construct is well expressed in
human ﬁbroblasts or HEK293 cells yielding a protein band of about
46 kDa. The TMEM70 gene encodes 260 amino acids protein of expected
MW of 29.0 kDa and the tagged TMEM70-GFP protein of 260+238
amino acids has calculated MW of 55.9 kDa. The difference between
calculated and observed size of the TMEM70-GFP is ~10 kDa and
corresponds well with predicted cleavable N-terminal sequence of 81
aminoacids (Fig. 1C). Similar experimentusing TMEM70-FLAG construct
(Fig. 1B) revealed the size of expressed protein of approximately 22 kDa
and thus both tagged forms of the TMEM70 supported the conclusion
that this protein is synthesized as a precursor that is processed into a
~21 kDa mature form of 179 AA.
To obtain speciﬁc antibodies to TMEM70 protein, we have
expressed mature part of TMEM70 in a form of a fusion protein
with maltose binding protein (MBP-TMEM70) in E. coli. Resulting
protein was isolated and used for immunization. As shown by SDS-
PAGE/WB analysis in Fig. 2, the anti-TMEM70 antibody recognized aestern blot detection of TMEM70 by polyclonal antibody in human heart homogenate
it) and TMEM70 in ﬁbroblast mitochondria from control (C1, C2) and indicated patients
Fig. 3. Subcellular localization of TMEM70-FLAG with respect to MitoTracker Red or ATP synthase in human ﬁbroblasts. Last column represents an overlay of the ﬁrst two columns
and shows cell nuclei stained with DAPI (blue).
Fig. 4. Import of TMEM70 to mitochondria. In vitro translated human fumarase (A) and
TMEM70 (B) were processed and imported to isolated rat liver mitochondria. Upon the
import, the mature forms of both proteins resisted to trypsin and their import was
prevented by uncoupler of oxidative phosphorylation FCCP.
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concentrated in isolated mitochondria (10,000g). The immunoreac-
tive band was absent in ﬁbroblast mitochondria (Fig. 2B) of the
patients with ATP synthase deﬁciency due to the homozygous
TMEM70 mutation c.317-2ANG. This mutation at the second intron
of TMEM70 gene has been shown to results in aberrant splicing and
loss of TMEM70 mRNA [10]. WB with anti-TMEM70 antibody thus
conﬁrmed previous conclusion that normal TMEM70 protein is absent
in patient mitochondria. There was no immunoreactive band at lower
molecular weight region indicating that no aberrant TMEM70 protein
is produced in patient cells.
The presence of TMEM70 protein was also veriﬁed by mass
spectrometry. LC-MS/MS analysis performed on mitochondria, whole
tissue homogenates or 100,000gmicrosomal fraction fromhumanheart
and mouse heart or liver did not detect the TMEM70 protein. However,
when a targeted approach was used (Supplementary Fig. S1), based on
the knowledge of the retention time, precise mass and fragmentation
spectrum of the human TMEM70 protein (MS/MS analysis of MBP-
humanTMEM70 fusion protein), TMEM70 HVFTTFYAK tryptic peptide
that is not present in any other human protein was found in the
approximately 18–23 kDa region sample of isolated human heart
mitochondria. MS analysis thus conﬁrmed mitochondrial location of
TMEM70 and further indicated that the cellular content of the TMEM70
is very low.
This conclusion is also supported by existing expression proﬁle
data (http://biogps.gnf.org/), which show that the level of TMEM70
transcripts is extremely low in human cells and tissues (Supplemen-
tary Fig. S2), being several orders of magnitude lower than the level of
mRNAs for structural subunits of ATP synthase (e.g. ATP5B mRNA for
F1 β subunit). The TMEM70mRNA levels are thus similarly low as the
levels of transcripts of ATPAF1 and ATPAF2 assembly factors [1], the
content of which is very small in mammalian tissues (Supplementary
Fig. S2 and [22]). Furthermore, TMEM70 transcripts show very smallvariation among various tissues, similarly as ATPAF2, characteristic for
housekeeping genes. All these data thus support the view that the
TMEM70 protein, ancillary factor of ATP synthase biogenesis is a low
abundant mitochondrial protein, not exerting tissue-speciﬁcity.
Cellular localization of TMEM70 protein was further analyzed at a
morphological level in cultured ﬁbroblasts. For experiments the cells
transfected with tagged TMEM70 or control cells expressing the
wtTMEM70 were used. As shown in Fig. 3, in cells transfected with
Fig. 5. TMEM70 is a membrane bound mitochondrial protein. HEK293 cells were transfected with TMEM70-FLAG and (A) cell homogenate, isolated mitochondria and cytosolic
fractions were analyzed. (B) Isolated mitochondria were sonicated and extracted with Na2CO3 and 100,000g pellet and supernatant were prepared. Western blot was performed
with indicated antibodies.
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antibody colocalized with the signal of MitoTracker Red and with the
signal of mitochondrial ATP synthase, detected with antibody to β
subunit of the F1 catalytic part, in accordance with previously
demonstrated mitochondrial localization of TMEM70-GFP [13].
Antibody to TMEM70 protein also conﬁrmed mitochondrial localiza-
tion in control cells, but it was less speciﬁc in immunocytochemical
experiments (not shown).
To assess further the basic properties of TMEM70 import to
mitochondria, we have synthesized radioactive TMEM70 in vitro using
coupled transcription-translation system and followed its import to
isolated mitochondria. For comparison, we analyzed import of matrix
located fumarase, as an example of mitochondrial protein that is
synthesized with cleavable N-terminal sequence. As shown in Fig. 4A,
the import analyses with isolated liver mitochondria showed a 56 kDa
precursor and a 52 kDa mature form of fumarase, with expected
sensitivity to trypsin and/or uncoupler. Analysis of TMEM70 protein
revealed ~29 kDa band produced by in vitro translation and additional
band of ~20 kDa present in the mitochondrial pellet. The 29 kDa band
was sensitive to protease indicating its extramitochondrial localiza-
tion typical for a precursor form. The 20 kDa band was resistant to
protease but it disappeared in the presence of uncoupler, thus
conﬁrming the intramitochondrial localization of the TMEM70
mature form. Interestingly, there was only small amount of the
mature 20 kDa protein found relative to the amount of precursorFig. 6. DDM-solubilized mitochondrial proteins reveal a dimeric form of TMEM70. Fibroblast
analyzed by two-dimensional electrophoresis (BN/SDS-PAGE) and WB using antibodies to
(higher intensity signal shown on the right).added. These data indicate that upon cleavage of the N-terminal part,
the mature TMEM70 is rather labile at the conditions of in vitro import
assay, or that additional cellular components are required for its
import in vivo. However, similar pattern was observed when using
mitochondria of human origin isolated from HEK293 cells or in co-
translational import assay.
To characterize further the mitochondrial localization of TMEM70,
we have investigated HEK293 cells expressing the TMEM70-FLAG
construct, which is only slightly larger than the wtTMEM70. When we
have isolated mitochondria from the cells expressing the TMEM70-
FLAG protein, we found that the TMEM70-FLAGwas fully recovered in
mitochondria while it was absent in the cytosolic fraction (Fig. 5A).
Then we fractionated the isolated mitochondria by sonication and
treated the mitochondrial membranes with Na2CO3. Analysis of
100,000g pellet and supernatant by SDS-PAGE and WB (Fig. 5B)
fully recovered the TMEM70-FLAG in the sediment, similarly as
cytochrome c oxidase (COX), indicating its localization in the
mitochondrial membrane. Efﬁciency of the treatments was veriﬁed
by antibody to matrix located HSP70 that was quantitatively
recovered in the soluble fractions.
Finally, to search for native conformation of TMEM70, we have
extracted ﬁbroblast mitochondria with mild detergent dodecyl
maltoside (DDM) and analyzed the solubilized proteins by two-
dimensional BN-PAGE/SDS-PAGE and WB. As demonstrated in Fig. 6,
TMEM70 was found as two spots of identical mobility in the secondmitochondria were solubilized with DDM (1 g/g protein) and 30,000g supernatant was
indicated proteins. Dashed line frames the region probed with anti-TMEM70 antibody
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dimension BN-PAGE gel was approximately 20 and 40 kDa. Parallel
detection of ATP synthase and respiratory chain complexes did not
reveal any association of TMEM70 with the assembled ATP synthase
complex or free α or β subunits and indicated that TMEM70 exists in
monomeric and dimeric forms when solubilized with detergent DDM.
Taken together, our experiments convincingly demonstrated that
TMEM70 is a membrane bound 21 kDa mitochondrial protein that is
synthesized as a 29 kDa precursor. TMEM70 is ﬁrmly associated with
inner mitochondrial membrane and it does not interact directly with
the ATP synthase complex. Very low cellular content of this protein,
analogous to low content of ATPAF1 and ATPAF2 chaperones [23]
supports the view of a regulatory― catalytic role of TMEM70 in ATP
synthase biogenesis. It also indicates that putative interacting partner of
TMEM70mightbe similarly low-abundant protein(s), as are for example
F1 assembly intermediates [24]. A larger form of TMEM70 on two-
dimensionalgels appears tobeadimer according to calculatedmolecular
weight, but we cannot exclude that it represents TMEM70 interacting
with some other protein, although it cannot be the large ATP synthase
subunits. Absence of TMEM70 in patient cells containing small amounts
of functionalATP synthase complex [10,11] indicates that TMEM70 is not
absolutely essential for ATP synthase biogenesis. Further studies are
needed to elucidate the biological role of this factor. A unique speciﬁcity
of TMEM70 to higher eukaryotes prevents the use of yeast cells, but the
studies utilizing overexpression of TMEM70, various tagged forms as
well as crosslinking and preparation of antibodies allowing for speciﬁc
immunoprecipitation may represent a perspective strategy.
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